8-K 1 c60006e8-k.txt CURRENT REPORT 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 --------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 7, 2001 ------------------------------- Ampersand Medical Corporation -------------------------------------------------------------------------------- (Exact name of Registrant as Specified in Charter) Delaware 0-935 36-4296006 -------------------------------------------------------------------------------- (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 414 North Orleans Street, Suite 510, Chicago, Illinois 60622 -------------------------------------------------------------------------------- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (312)222-9550 ----------------------------- -------------------------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) 2 Item 5. Other Events On February 7, 2001, Ampersand Medical Corporation and its subsidiary, AccuMed Acquisition Corp., and AccuMed International, Inc. entered into an Agreement and Plan of Merger. A copy of the press release announcing execution of the Agreement and Plan of Merger is attached hereto as Exhibit 99.1 and incorporated by reference herein. Item 7. Financial Statements and Exhibits (c) Exhibits 99.1. Press Release of Ampersand Medical Corporation, dated February 7, 2001. 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMPERSAND MEDICAL CORPORATION ----------------------------- (Registrant) Date February 9, 2001 By /s/ Leonard Prange ---------------------- ---------------------------------- Leonard Prange, President 4 EXHIBIT INDEX EXHIBIT NUMBER DESCRIPTION ------ ----------- 99.1 Press Release of Ampersand Medical Corporation dated February 7, 2001.